all trials up to this point have been above expectations.
you'd expect more of the same going forward and with these trials. but when you deliver amazing results you need to be sure you haven't missed anything otherwise it derails the whole process. It's annoying, but I'd rather they double-check the results or clean up any holes that need plugging, especially if it's not delaying our human trials next year. This needs to be watertight!
Ann: Update on ALA-101 and onCARlytics research collaboration, page-5
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
-0.015(7.69%) |
Mkt cap ! $189.6M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.0¢ | $399.1K | 2.143M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 858513 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 131746 | 3 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| ALA (ASX) Chart |